Jacobs Levy Equity Management, Inc Puma Biotechnology, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.13 - $3.24 $1.61 Million - $2.45 Million	-756,675 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.85 - $6.58 $893,742 - $2.06 Million	313,594 Added 70.78%	756,675 $2.3 Million
Q3 2021 Nov 15, 2021	BUY	$6.63 - $9.39 $1.74 Million - $2.46 Million	262,137 Added 144.87%	443,081 $3.11 Million
Q2 2021 Aug 16, 2021	BUY	$8.98 - $11.6 $56,133 - $72,511	6,251 Added 3.58%	180,944 $1.66 Million
Q1 2021 May 17, 2021	BUY	$9.38 - $13.63 $667,527 - $969,978	71,165 Added 68.74%	174,693 $1.7 Million
Q4 2020 Feb 16, 2021	SELL	$7.78 - $12.13 $7,896 - $12,311	-1,015 Reduced 0.97%	103,528 $1.06 Million
Q3 2020 Nov 16, 2020	SELL	$9.5 - $11.14 $39,387 - $46,186	-4,146 Reduced 3.81%	104,543 $1.06 Million
Q2 2020 Aug 17, 2020	BUY	$7.01 - $13.24 $176,960 - $334,230	25,244 Added 30.25%	108,689 $1.13 Million
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $268,344 - $622,576	-42,730 Reduced 33.87%	83,445 $704,000
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $138,807 - $229,139	21,355 Added 20.37%	126,175 $1.1 Million
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $581,525 - $854,011	66,460 Added 173.25%	104,820 $1.13 Million
Q2 2019 Aug 13, 2019	SELL	$12.3 - $35.76 $64,206 - $186,667	-5,220 Reduced 11.98%	38,360 $488,000
Q1 2019 May 14, 2019	BUY	$20.77 - $42.37 $540,850 - $1.1 Million	26,040 Added 148.46%	43,580 $1.69 Million
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $247,463 - $575,811	12,330 Added 236.66%	17,540 $357,000
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $214,652 - $311,818	5,210 New	5,210 $239,000
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $435,630 - $724,227	-7,297 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$93.85 - $132.45 $684,823 - $966,487	7,297	7,297 $721,000

Others Institutions Holding PBYI

# of Institutions

102

Shares Held

29M

Call Options Held

60.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$11.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$10.9 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$9.31 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$8.76 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.99 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account